Sun Pharmaceuticals settles drug patent litigation with pharma giants
Date: 2018-01-17   Author: Dhananjay Punekar  Category: #industry

Sun Pharmaceuticals settles drug patent litigation with pharma giants

Sun Pharmaceuticals Industries Limited, a key player across the pharmaceuticals industry, has reportedly entered into a pact with Pharma giants Allergan Plc & Ironwood Pharmaceuticals Inc. for resolving the patent dispute over the Linzess drug in the United States.

According to some of the key officials of Sun Pharma, the case related to the drug patent was filed against the firm in response to its abbreviated new drug application under which Sun Pharma is seeking USFDA approval for promoting the generic form of Linzess drug. Medical practitioners have stated that the prescribed medicine is used in treating chronic idiopathic constipation and irritable bowel syndrome in the elderly. As per statistics, the revenue from the sale of the drug had hit USD 506 million in the third quarter of last year, demonstrating a 12% y-o-y growth. It has been reported that in the last quarter of 2017 however, Linzess recorded sales worth USD 191 million, a growth of nearly 16% y-o-y.  As per the market projections, the drug is likely to accrue a revenue of over USD 1 billion as a result of its high demand and favorable purchasing patterns.

As a part of the deal, Ironwood Pharmaceuticals and Allergan Plc will provide a license to Sun Pharmaceuticals to promote Linzess generic across the U.S., effective from 1st February 2031, or even prior to this date, subject to specific conditions. It has been learnt that after the settlement, the patent lawsuit against Sun Pharmaceuticals filed by the two pharma giants will be dismissed. However, as per the key officials of Sun Pharma, the pact is still subject to normal regulatory approvals.

Industry analysts have anticipated that the settlement will have a positive impact on the business growth of Sun Pharma. After the firm’s strategic decision to settle the patent dispute, the firm’s stocks had jumped up from INR 576.40 to INR 578.10 yesterday.



About Author


Dhananjay Punekar

Dhananjay Punekar

Dhananjay currently works as a content writer at AlgosOnline. A post graduate in mathematics as well as business administration, he worked as a process executive in Infosys BPO Limited before switching his professional genre. Following his childhood passion, he opted fo...

Read More

More from Dhananjay


Post Recommendents

Global Industrial control computer Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2024
Author: Partha Ray

The ' Industrial control computer market' research report added by Market Study Report, LLC, is an in-depth analysis of the latest trends persuading the business outlook. The report also offers a concise summary of statistics, market valua...


Gesture Recognition Touchless Sensing Market Size, Historical Growth, Analysis, Opportunities and Forecast To 2024
Author: Partha Ray

The ' Gesture Recognition Touchless Sensing market' study now available at MarketStudyReport.com, is a detailed sketch of the business sphere in terms of current and future trends driving the profit matrix. The report also indicates a poin...


Trends of Generator Parts Accessories Market Reviewed for 2019 with Industry Outlook to 2024
Author: Partha Ray

The ' Generator Parts Accessories market' research report is latest addition by Market Study Report, LLC, that elucidates relevant market and competitive insights as well as regional and consumer information. In a nutshell, the research st...